Operating Expenses Summary of Gerresheimer AG

Gerresheimer AG's latest annual operating expenses in 2023 was 383.92 Million EUR , up 12.32% from previous year.
Gerresheimer AG's latest quarterly operating expenses in 2024 Q3 was 99.45 Million EUR , up 0.82% from previous quarter.
Gerresheimer AG reported a annual operating expenses of 327.51 Million EUR in annual operating expenses 2022, up 24.34% from previous year.
Gerresheimer AG reported a annual operating expenses of 263.39 Million EUR in annual operating expenses 2021, up 2.22% from previous year.
Gerresheimer AG reported a quarterly operating expenses of 89.31 Million EUR for 2024 Q2, down -8.59% from previous quarter.
Gerresheimer AG reported a quarterly operating expenses of 99.45 Million EUR for 2024 Q3, up 0.82% from previous quarter.

Annual Operating Expenses Chart of Gerresheimer AG (2023 - 2005)

Historical Annual Operating Expenses of Gerresheimer AG (2023 - 2005)

Year	Operating Expenses	Operating Expenses Growth
2023	383.92 Million EUR	12.32%
2022	327.51 Million EUR	24.34%
2021	263.39 Million EUR	2.22%
2020	257.67 Million EUR	5.36%
2019	244.56 Million EUR	0.11%
2018	244.31 Million EUR	2.47%
2017	238.41 Million EUR	-5.36%
2016	251.91 Million EUR	-0.57%
2015	253.35 Million EUR	16.43%
2014	217.6 Million EUR	-3.49%
2013	225.45 Million EUR	-1.29%
2012	228.4 Million EUR	7.8%
2011	211.88 Million EUR	2.33%
2010	207.05 Million EUR	2.87%
2009	201.28 Million EUR	-11.4%
2008	227.19 Million EUR	9.14%
2007	208.15 Million EUR	424.89%
2006	-64.07 Million EUR	-22.32%
2005	-52.38 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	97.7 Million EUR	31.79%
2024 Q2	89.31 Million EUR	-8.59%
2024 Q3	99.45 Million EUR	0.82%
2023 Q3	96.22 Million EUR	1.88%
2023 Q4	74.14 Million EUR	-22.95%
2023 FY	367.85 Million EUR	12.32%
2023 Q1	103.03 Million EUR	85.01%
2023 Q2	94.45 Million EUR	-8.33%
2022 Q3	102.51 Million EUR	13.84%
2022 Q4	55.69 Million EUR	-45.67%
2022 FY	327.51 Million EUR	24.34%
2022 Q2	90.04 Million EUR	13.62%
2022 Q1	79.25 Million EUR	71.82%
2021 Q2	75.78 Million EUR	23.12%
2021 Q4	46.12 Million EUR	-42.29%
2021 FY	263.39 Million EUR	2.22%
2021 Q1	61.55 Million EUR	10.13%
2021 Q3	79.93 Million EUR	5.48%
2020 Q1	67.79 Million EUR	-58.47%
2020 FY	257.67 Million EUR	5.36%
2020 Q4	55.89 Million EUR	-6.22%
2020 Q3	59.6 Million EUR	-19.88%
2020 Q2	74.39 Million EUR	9.74%
2019 Q4	163.24 Million EUR	153.25%
2019 Q3	64.45 Million EUR	50.37%
2019 Q2	42.86 Million EUR	-38.12%
2019 Q1	69.27 Million EUR	16.32%
2019 FY	244.56 Million EUR	0.11%
2018 Q1	63.74 Million EUR	-2.54%
2018 FY	244.31 Million EUR	2.47%
2018 Q3	60.95 Million EUR	1.49%
2018 Q2	60.05 Million EUR	-5.78%
2018 Q4	59.55 Million EUR	-2.3%
2017 Q1	60.19 Million EUR	23.19%
2017 Q3	52.73 Million EUR	-12.22%
2017 Q4	65.4 Million EUR	24.02%
2017 Q2	60.07 Million EUR	-0.2%
2017 FY	238.41 Million EUR	-5.36%
2016 Q3	68.46 Million EUR	1.45%
2016 Q2	67.48 Million EUR	0.57%
2016 Q4	48.86 Million EUR	-28.62%
2016 FY	251.91 Million EUR	-0.57%
2016 Q1	67.1 Million EUR	-7.81%
2015 Q4	72.78 Million EUR	9.31%
2015 Q1	52.71 Million EUR	-1.63%
2015 Q3	66.58 Million EUR	8.66%
2015 FY	253.35 Million EUR	16.43%
2015 Q2	61.27 Million EUR	16.25%
2014 Q1	52.86 Million EUR	-3.29%
2014 FY	217.6 Million EUR	-3.49%
2014 Q4	53.58 Million EUR	-4.58%
2014 Q3	56.15 Million EUR	2.09%
2014 Q2	55 Million EUR	4.04%
2013 FY	225.45 Million EUR	-1.29%
2013 Q1	54.26 Million EUR	-0.63%
2013 Q2	62.35 Million EUR	14.92%
2013 Q4	54.66 Million EUR	0.91%
2013 Q3	54.17 Million EUR	-13.13%
2012 Q4	54.6 Million EUR	-8.27%
2012 Q1	57.23 Million EUR	2.58%
2012 FY	228.4 Million EUR	7.8%
2012 Q2	57.39 Million EUR	0.29%
2012 Q3	59.53 Million EUR	3.73%
2011 Q2	54.92 Million EUR	10.55%
2011 Q1	49.67 Million EUR	-1.92%
2011 Q3	51.48 Million EUR	-6.25%
2011 Q4	55.79 Million EUR	8.36%
2011 FY	211.88 Million EUR	2.33%
2010 Q3	57.23 Million EUR	12.62%
2010 Q1	48.55 Million EUR	7.01%
2010 Q4	50.65 Million EUR	-11.5%
2010 Q2	50.81 Million EUR	4.66%
2010 FY	207.05 Million EUR	2.87%
2009 Q2	59.56 Million EUR	20.25%
2009 FY	201.28 Million EUR	-11.4%
2009 Q1	49.53 Million EUR	0.0%
2009 Q3	46.88 Million EUR	-21.28%
2009 Q4	45.37 Million EUR	-3.22%
2008 FY	227.19 Million EUR	9.14%
2007 FY	208.15 Million EUR	424.89%
2006 FY	-64.07 Million EUR	-22.32%
2005 FY	-52.38 Million EUR	0.0%

Peer Operating Expenses Comparison of Gerresheimer AG

Name	Operating Expenses	Operating Expenses Difference
SCHOTT Pharma AG & Co. KGaA	124.1 Million EUR	-209.351%
Carl Zeiss Meditec AG	878.62 Million EUR	56.304%
Fielmann Aktiengesellschaft	289.86 Million EUR	-32.449%
Sartorius Aktiengesellschaft	1.02 Billion EUR	62.504%
Sartorius Aktiengesellschaft	1.02 Billion EUR	62.453%

Global Stocks Search

Gerresheimer AG (GXI.DE)

Operating Expenses Summary of Gerresheimer AG

Annual Operating Expenses Chart of Gerresheimer AG (2023 - 2005)

Historical Annual Operating Expenses of Gerresheimer AG (2023 - 2005)

Peer Operating Expenses Comparison of Gerresheimer AG